Daily Archives: January 28, 2016

Medical advisory on St. Jude Optisure dual coil defibrillation leads for implantable cardioverter defibrillators

Posted on by

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that a previously communicated voluntary global field safety action related to the company’s Optisure™ Dual Coil Defibrillation Leads has now been classified as a Class 1 Advisory by the U.S. Food and Drug Administration. The Class 1 Advisory relates to a limited and well-defined group of 447 Optisure leads, 278 of which were distributed in the U.S., which may have been damaged during a manufacturing step. The company has received no reports of lead malfunction or patient injury related to this issue and all physicians with patients impacted by this advisory have been notified.

Optisure dual coil defibrillation leads are used in conjunction with implantable cardioverter defibrillators (ICDs), which monitor the heartbeat of patients suffering from heart rhythm disorders. An ICD’s leads deliver electric current to the heart to help restore the heart to its normal rhythm when needed.

On November 3, 2015, St. Jude Medical began the global process of notifying physicians following patients who have been implanted with the 447 Optisure dual coil leads subject to this advisory. An investigation revealed a variation in the process to remove excess medical adhesive used in the assembly of the superior vena cava (SVC) shock coil in a limited and well-defined group of Optisure leads could result in cuts to the insulation of the lead. Depending on device programming and the depth of the inadvertent cut to the insulation, compromise of lead insulation can potentially lead to an electrical malfunction wherein the defibrillator cannot deliver appropriate high voltage therapy.

A St. Jude Medical internal investigation found the probability that a lead was damaged as a result of the manufacturing variation to an extent that it could result in the inability to deliver appropriate high voltage therapy is very low and that any associated risks can be prevented with device reprogramming. The patients’ leads can also be monitored from home using the Merlin.net™ remote care system. The company has not received any reports of compromised performance of the impacted Optisure leads. St. Jude Medical is in the process of providing an updated advisory notice to physicians to further ensure physicians are aware of recommendations for managing their patients who may have been implanted with the impacted leads.

The advisory notification involves the worldwide distribution of 447 Optisure dual coil defibrillation leads manufactured and distributed by St. Jude Medical. The advisory relates to units within the following models: LDA220, LDA220Q, LDA230Q, and LDP220Q.

The vast majority of patients implanted with the Optisure leads compromised by the advisory have devices equipped with the St. Jude Medical DynamicTx™ feature that provides additional protection to help ensure delivery of appropriate high voltage therapy even in the case of a compromised lead. For these patients, physicians are advised to enroll patients in the Merlin.net patient care network, ensure the DynamicTx feature is programmed “on” and then monitor patients as per normal follow-up protocols.

Physicians following the 9 patients in the U.S. with compromised leads not connected to a device with the DynamicTx feature have been advised to enroll these patients in the Merlin.net patient care network and, where appropriate, consider turning off the SVC coil. If a dual coil shocking configuration is desired, physicians should consider performing a high voltage test when clinically appropriate to determine whether the lead has been compromised. As of this letter all physicians following the 9 patients have been contacted and provided information about this event.

Patient safety is St. Jude Medical’s highest priority, and the company will continue to work closely with customers and global regulatory agencies to ensure effective communication to our physician partners. The company has alerted all physician customers impacted by the advisory by letter, and all leads subject to this advisory have been accounted for and none remain in any field distribution. The U.S. Food and Drug Administration and other regulatory bodies have been notified. For more information, patients or their physicians can visit www.sjm.com/optisureadvisorydisclaimer icon or call the St. Jude Medical customer service team 24 hours a day at (800) 328-9634.

Overseeing cleanups, ADOT looks out for the environment ‒ and taxpayers

Posted on by

PHOENIX — When fuel and other hazardous materials spill along our highways, the Arizona Department of Transportation makes sure the messes are cleaned up properly ‒ and that taxpayers aren’t stuck with the bill.

During 2015, ADOT’s Hazardous Materials Response Team saved an estimated $2.6 million by making the commercial carriers responsible or their insurance companies pay to remove contaminants from the soil. Taxpayers would otherwise be responsible for these environmental remediation costs, and the state would have been liable for fines and sanctions if the spills weren’t addressed properly.

Most of the 150 to 250 hazardous materials incidents ADOT responds to each year involve fuel spilling from trucks involved in crashes. About 40 to 50 incidents each year involve shipments of hazardous materials including fuel and acids.

Thanks to the Hazardous Materials Response Team’s efforts, all but a handful of the cleanups are paid for by commercial carriers or insurance companies.

“ADOT is committed to environmental responsibility and making the most efficient use of funds,” ADOT Director John Halikowski said. “The record of success the Hazardous Materials Response Team has established over the years preserves money for transportation needs.”

When a hazardous materials spill occurs, public safety is the first priority for ADOT and other agencies responding. After that, ADOT makes sure those responsible pay to clean up the road and right of way using contractors approved by the Arizona Department of Environmental Quality.

“It’s just doing the right thing not only for ADOT but for the taxpayers of Arizona,” said Travis V. Qualls, the agency’s hazardous materials response specialist. “Why should we be paying for someone else releasing a hazardous material on our property?”

ADEQ requires a higher level of cleanup in residential areas, but ADOT requires the residential standard regardless of where a spill occurs. The contractor handling a cleanup must complete work as instructed by

ADOT and provide the samples of soil before and after as well as documentation of where contaminated soil is taken.